A big Charlotte-area employer is long-gone. So why is it getting an $11M tax refund now?
Philip Morris, once one of the biggest employers and taxpayers in Cabarrus County, is suddenly in line to get more than $11 ...
Philip Morris' shares rise on optimistic 2025 outlook
Cigarette giant Philip Morris International on Thursday forecast better-than-expected profit growth for 2025, with ...
Philip Morris: No Margin Of Safety
Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...
Philip Morris International (PM) Q4 2024 Earnings Call Transcript
Welcome to the Philip Morris International fourth quarter 2024 and full year results conference call. [Operator instructions] ...
Analysts Fail to Light Up Philip Morris Stock Despite Price Target Hikes
Tobacco group Philip Morris (PM) has fired up some key analysts after posting strong Q4 earnings. Four-star TipRanks-rated ...
Yahoo5d
Philip Morris Stock Is Rising. Earnings Guidance Was Big.
Tobacco firm Philip Morris’ 2025 earnings guidance easily topped expectations, overshadowing the fourth-quarter report. Philip Morris International Inc (PM) Q4 2024 Earnings Call Highlights ...
PM Earnings: Philip Morris Stock Soars on Strong Q4 Beats
Philip Morris (PM) stock soared higher today after posting its earnings report for Q4 2024. The tobacco company’s adjusted ...
MarketWatch2d
Philip Morris’s stock touches record high as outlook tops Wall Street estimates
Philip Morris International Inc.’s stock touched a record high on Thursday after the company issued a profit outlook that topped Wall Street analyst expectations on strength in its smokeless ...
Money Morning4d
3 Reasons Why Philip Morris International Is the Best Tobacco Stock to Buy
Global tobacco giant Philip Morris International (PM) shocked the world a few years ago when it declared it would pursue a ...
Philip Morris International: Market Is Underestimating The Company's True Growth Prospects
Philip Morris' impressive Q3 results highlight robust performance in both core and reduced-risk products. Read why I remain ...